Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 17, Issue 3

May-June 2020

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Headlines from Washington
Image Challenge
Mini Review
No Data Zone
President’s Column

Ask the Hematologist

How to Use a Geriatric Assessment in an Older Patient With Acute Myeloid Leukemia

Heidi D. Klepin, MD, MS,Kah Poh (Melissa) Loh, MBBCh, BAO

View Articletitled, How to Use a Geriatric Assessment in an Older Patient With Acute Myeloid Leukemia

Clinical Trials Corner

Adjusting How We Diagnose Deep Vein Thrombosis

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Adjusting How We Diagnose Deep Vein Thrombosis

Bringing Immunotherapy to the Front Line in Childhood Leukemia

David T. Teachey, MD,Stephanie J. Si, MD

View Articletitled, Bringing Immunotherapy to the Front Line in Childhood Leukemia

Diffusion

Can Leuk-warm Be Hot? Heating Up the Debate of Non-canonical Hotspot Spliceosomal Mutations in Myeloid Pathogenesis

Amy DeZern, MD, MHS,Andrew H. Marple, MD, PhD

View Articletitled, Can Leuk-warm Be Hot? Heating Up the Debate of Non-canonical Hotspot Spliceosomal Mutations in Myeloid Pathogenesis

Lower Risk for Fractures Is Another Win for Direct Oral Anticoagulants

Damon Houghton, MD

View Articletitled, Lower Risk for Fractures Is Another Win for Direct Oral Anticoagulants

Promising Preclinical Results for Immunotherapy in Multiple Myeloma

Mark Bustoros, MD,Irene M. Ghobrial, MD

View Articletitled, Promising Preclinical Results for Immunotherapy in Multiple Myeloma

CD19 Chimeric Antigen Receptor Natural Killer Cells Can Safely Induce Remission in Lymphoid Malignancies

Frederick Locke, MD

View Articletitled, CD19 Chimeric Antigen Receptor Natural Killer Cells Can Safely Induce Remission in Lymphoid Malignancies

Are We Capable of Curing Follicular Lymphoma, But Just Afraid to Say It?

Brad Kahl, MD

View Articletitled, Are We Capable of Curing Follicular Lymphoma, But Just Afraid to Say It?

Gut Microbiome Diversity Influences Transplant Risk

Steven Lane, MBBS, PhD, FRACP, FRCPA,Julian Grabek, MBBS, FRACP, FRCPA

View Articletitled, Gut Microbiome Diversity Influences Transplant Risk

Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

Annette S. Kim, MD, PhD,Ian Brain, MD

View Articletitled, Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

Features

In Anticipation of the Wave

Laura C. Michaelis, MD

View Articletitled, In Anticipation of the Wave

Headlines from Washington

Hematology Advocates Raise Palliative Care Issues With Congress

ASH Staff

View Articletitled, Hematology Advocates Raise Palliative Care Issues With Congress

Image Challenge

Hyperbilirubinemia in Myelodysplastic Syndromes

Peter Greenberg, MD,Jason Kurzer, MD, PhD

View Articletitled, Hyperbilirubinemia in Myelodysplastic Syndromes

Mini Review

T-cell Lymphoblastic Leukemia: What Are the Prospects for Novel Immunotherapy?

Kristen M. O'Dwyer, MD

View Articletitled, T-cell Lymphoblastic Leukemia: What Are the Prospects for Novel Immunotherapy?

No Data Zone

Transplantation in Sickle Cell Disease: Who, When, and How

Javier Bolaños-Meade, MD

View Articletitled, Transplantation in Sickle Cell Disease: Who, When, and How

President’s Column

COVID-19: ASH's Response Draws on the Strength of Our Community

Stephanie Lee, MD, MPH

View Articletitled, COVID-19: ASH's Response Draws on the Strength of Our Community

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

How to Use a Geriatric Assessment in an Older Patient With Acute Myeloid Leukemia

Clinical Trials Corner

Adjusting How We Diagnose Deep Vein Thrombosis

Bringing Immunotherapy to the Front Line in Childhood Leukemia

Diffusion

Can Leuk-warm Be Hot? Heating Up the Debate of Non-canonical Hotspot Spliceosomal Mutations in Myeloid Pathogenesis

Lower Risk for Fractures Is Another Win for Direct Oral Anticoagulants

Promising Preclinical Results for Immunotherapy in Multiple Myeloma

CD19 Chimeric Antigen Receptor Natural Killer Cells Can Safely Induce Remission in Lymphoid Malignancies

Are We Capable of Curing Follicular Lymphoma, But Just Afraid to Say It?

Gut Microbiome Diversity Influences Transplant Risk

Using Artificial Intelligence to Enhance Diagnosis: Is Resistance Futile?

Features

In Anticipation of the Wave

Headlines from Washington

Hematology Advocates Raise Palliative Care Issues With Congress

Image Challenge

Hyperbilirubinemia in Myelodysplastic Syndromes

Mini Review

T-cell Lymphoblastic Leukemia: What Are the Prospects for Novel Immunotherapy?

No Data Zone

Transplantation in Sickle Cell Disease: Who, When, and How

President’s Column

COVID-19: ASH's Response Draws on the Strength of Our Community

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Headlines from Washington

Image Challenge

Mini Review

No Data Zone

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only